DALLAS & WOBURN, Mass.--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present “Innovations in kink-resistant ethylene vinyl acetate (EVA) copolymer formulations specially developed for single-layer medical tubing applications” on Tuesday, September 13 at the Medical Tubing 2016 conference in Woburn, Mass., highlighting the advantages of EVA polymers over PVC materials for medical bags and tubing.
“While PVC is still prevalent in the bag and tubing market, medical OEMs are looking for alternative materials,” said Bin Zhang, product development chemist at Celanese. “EVA polymers do not require plasticizers and there are no leachable or extractable concerns. Celanese’s Ateva® G EVA polymers have been widely used in total parenteral nutrition bag applications to support the efforts of major OEMs who want to achieve 100 percent non-PVC nutrition bag sets.”
“Celanese continues to invest in EVA polymer technologies and material sciences critical to our medical and pharmaceutical customer’s needs,” said Verghese Thomas, chief technology and innovation officer, Celanese. “Our EVA polymers are customized to meet critical internal quality parameters and are further supported by Celanese’s technical know-how to create solutions for our strategic customers.”
On the design and production front, tubing configurations are becoming more complex, including increasingly sophisticated multi-layer, multi-lumen and micro-bore designs. These must be produced to extremely tight tolerances and at higher throughputs to deliver cost efficiencies. At the Medical Tubing 2016 conference, leading experts will discuss how extrusion technologies are being developed and refined to meet these considerable challenges.
During the Celanese expert presentation, Zhang will focus on how EVA can be a solution in the development of kink-resistant EVA formulations. The presentation will highlight the advantages of Celanese EVA polymers and introduce details on development of kink-resistant EVA formulations for medical tubing applications.
|Topic:||“Innovations in kink-resistant ethylene vinyl acetate copolymer formulations specially developed for single-layer medical tubing applications”|
|Date:||Tuesday, September 13, 2016|
|Time(s):||2:10 p.m. Eastern time|
|Presenters:||Bin Zhang, Product Development Chemist, Celanese EVA Polymers|
For more information on Celanese’s medical and pharmaceutical solutions for medical technology applications, visit healthcare.celanese.com.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials Solutions, use the full breadth of Celanese’s global chemistry, technology and business expertise to create value for our customers and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,000 employees worldwide and had 2015 net sales of $5.7 billion. For more information about Celanese and our product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International Corporation or its affiliates.
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.